Résonance magnétique cardiaque (RMC) c’est une technique sans rayonnement, qui est considérée comme l’étalon-or pour l’évaluation de l’anatomie cardiaque, de la fonction et même de la composition des tissus. L’essai RESILIENCE utilisera la RMC comme principale méthodologie de mesure des résultats, et les patients inscrits à l’essai subiront 3 examens pendant toute la durée de l’étude.
Essai clinique multinational, prospectif, de preuve de concept de phase II, à double insu, contrôlé par simulation, randomisé (ECR) pour évaluer l’efficacité et l’innocuité du préconditionnement ischémique distal (RIC) chez les patients atteints de Lymphome recevant des anthracyclines. Les patients devant subir ≥5 cycles de chimiothérapie seront éligibles.
Supporting a friend or family member with this disease is not always easy, but there are some guidelines that can help manage it. Cancer is increasingly present in our lives. Facing the diagnosis and dealing with the disease is complicated for the patient, but also for their loved ones. We
One of the problems that oncology patients may face are diseases of the heart and cardiovascular system, both during treatment and once the disease has been overcome. In the next twenty years the incidence of cancer could increase by 70%, according to WHO estimates. Half of all patients will survive
Scientific studies link these sweeteners to the development of cancer and cardiovascular diseases. It is a fact that excessive sugar consumption is detrimental to health, as has been proven in several scientific studies. For this reason, in recent years the food industry has focused its efforts on finding a substitute
Healthy lifestyle habits are crucial to prevent cancer, but also to cope with cancer treatment and to recover physically and emotionally once the disease has been cured. Nowadays we often hear the word cancer, since the increase in life expectancy and the improvement in the early detection of this disease
Oncology research can be performed at the basic or clinical level, although the ideal is to connect both sectors to transform achievements in the laboratory into real changes for patients. In recent years, the field of oncology has made impressive advances. However, much of the progress made in laboratories is
Non-Hodgkin’s lymphoma is a disease that can be approached from different treatment alternatives. However, its prognosis depends on the type of lymphoma in question, with the most aggressive ones being the most responsive to therapy. When a person receives a diagnosis of Non-Hodgkin’s lymphoma, it is important that both the
